光医学技术市场－全球产业规模、份额、趋势、机会及预测（按应用、地区和竞争格局划分，2021-2031年）

全球光医疗技术市场预计将从 2025 年的 4.5102 亿美元成长到 2031 年的 6.2864 亿美元，复合年增长率为 5.69%。

该领域透过跨学科应用光疗技术，包括雷射、强力脉衝光和动态疗法，应对各种美容和医疗挑战。推动这一领域发展的关键因素包括：全球人口快速老化，老年人更容易患上慢性皮肤病；以及患者越来越倾向于选择微创、恢復期短的治疗方式。此外，皮肤病和肿瘤疾病发生率的上升也需要精准的光治疗性介入，从而形成不受消费趋势影响的根本需求。

儘管成长前景良好，但该市场仍面临许多挑战。高昂的资本成本，尤其是医用雷射系统，限制了小规模医疗机构的进入。此外，关于设备安全性和潜在副作用的严格监管也阻碍了产品的快速商业化。根据美国皮肤外科协会 (ASDS) 2025 年的一项调查，70% 的消费者对美容手术感兴趣，其中雷射除毛最受关注。这种强烈的消费意愿支撑着对光医学解决方案的强劲需求，前提是能够有效克服经济和监管方面的挑战。

市场驱动因素

眼科和皮肤科疾病发生率的上升是推动光医学技术应用的主要因素。慢性疾病和皮肤恶性肿瘤的日益增多，使得精准的诊断和治疗工具（例如先进的雷射系统和动态疗法）的需求变得迫切。这些技术能够标靶治疗病灶，同时最大限度地减少对周围组织的损伤，已成为现代肿瘤学和皮肤病学不可或缺的一部分。美国癌症协会于2025年1月发布的《2025年癌症事实与数据》报告强调了这种紧迫性，该报告预测，到2025年，美国将新增212,200例黑色素瘤病例，凸显了光治疗方法在复杂皮肤疾病治疗中的关键作用。

同时，微创美容手术需求的激增正在改变市场格局。患者越来越倾向于选择能够有效改善肤质且无需传统手术恢復期和风险的美容方式，这推动了非手术紧肤设备和雷射皮肤修復的普及。技术创新进一步强化了这一趋势，并提高了各种肤质的安全性和有效性。根据国际美容整形外科学会 (ISAPS) 于 2025 年 6 月发布的《全球美容整形外科调查报告》，2024 年全球非手术美容手术量将达到 2,050 万例，这标誌着微创方式的大规模普及。这一商业性成功也体现在行业业绩上。例如，Sisram Medical 于 2025 年 3 月宣布，其 2024 财年总营收为 3.491 亿美元，主要得益于该公司能量型医疗设备产品组合的强劲销售。

市场挑战

先进光疗系统所需的巨额资本投入是雷射技术广泛应用的一大障碍，直接阻碍了市场扩张。医用级设备给医疗服务提供者带来了沉重的经济负担，尤其是对于缺乏大型医院网路雄厚财力的独立皮肤科医生和小规模美容诊所而言。高昂的进入门槛迫使从业者维持高昂的治疗价格以确保投资回报，从而有效地阻碍了这些服务的商品化。这使得这项技术在经济上难以惠及更广泛的受众，将潜在市场规模限制在富裕患者群体，并抑制了其向大众市场的渗透。

这种经济摩擦直接阻碍了消费者兴趣转化为实质收入成长。这些设备成本的下游影响在患者对治疗经济性的态度上显而易见：美国皮肤外科协会 (ASDS) 2025 年的一项调查发现，24% 的消费者表示，费用是他们推迟或放弃理想美容手术的主要原因。这项数据表明，高成本技术的经济负担正在转嫁给患者，从而形成价格上限，显着限制了手术数量，阻碍了全球光医学技术市场的整体成长。

市场趋势

将人工智慧 (AI) 应用于精准剂量测定和个人化治疗，正从根本上重塑全球光医学技术市场，以自动化、数据驱动的通讯协定取代手动参数选择。这项技术进步使先进的雷射和光疗系统能够即时分析患者的皮肤特征，并动态调整能量密度和脉衝宽度，从而最大限度地提高治疗效果，同时最大限度地减少热损伤。製造商正日益重视这些智慧控制功能，以使他们的旗舰平台脱颖而出，并满足对一致临床结果且不受操作者差异影响的需求。这种对智慧自动化的策略关注正在带来切实可见的财务成果。根据 Sciton 公司在 2025 年 3 月发布的「28 年成长计画」公告，该公司的人工智慧增强型 BBL HEROic 系统正推动其光疗产品组合实现 7% 的年收入成长，这印证了市场正向智慧、自适应剂量测定技术转型。

同时，智慧穿戴式和手持式家用光疗设备的普及催生了一个庞大的次市场，与专业的临床服务相辅相成。在治疗组件小型化的推动下，消费者正迅速接受获得FDA批准的LED 面膜和手持式雷射设备，从而便捷地管理痤疮、脱髮症和光老化等皮肤问题。这一趋势有效地规避了专业医疗保健系统高昂的准入门槛，使製造商能够触及寻求便捷、持续护肤的广大消费者群体。这一消费群体的商业性规模正变得日益显着：根据City AM 2025年2月报道，家用设备零售商CurrentBody在2024年首次实现了年收入超过1亿英镑的突破，证实了市场对个性化光疗解决方案的爆炸式需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球光疗技术市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依应用领域划分（美容/皮肤科（除毛、纹身去除、皮肤修復等）、牙科手术、肿瘤科、眼科、疼痛管理、创伤治疗等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美光医学技术市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲光医学技术市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区光疗技术市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲光疗技术市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美光医学技术市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球光疗技术市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Sisram Medical Ltd
• Beurer GmbH
• Biolitec AG
• Koninklijke Philips NV
• Lumenis Inc.
• Photomedex Inc.
• LUMIBIRD Inc.
• Candela Corporation
• Thor Photomedicine Ltd
• Johnson & Johnson

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Photomedicine Technology Market is projected to expand from USD 451.02 Million in 2025 to USD 628.64 Million by 2031, exhibiting a CAGR of 5.69%. This sector involves the multidisciplinary use of light-based technologies, such as lasers, intense pulsed light, and photodynamic therapy, to address a wide range of aesthetic and medical conditions. Key factors driving this growth include a rapidly aging global demographic prone to chronic skin ailments and a growing patient preference for minimally invasive treatments that ensure shorter recovery periods. Additionally, the increasing frequency of dermatological and oncological cases requires precise, light-based therapeutic interventions, establishing a fundamental demand that exists independently of fleeting consumer trends.

Despite these favorable growth prospects, the market confronts significant obstacles, particularly the high capital costs associated with medical laser systems, which restrict access for smaller healthcare facilities. Furthermore, stringent regulations concerning device safety and potential side effects impede rapid product commercialization. According to the American Society for Dermatologic Surgery in 2025, 70% of consumers expressed interest in considering a cosmetic procedure, with laser hair removal emerging as the top area of interest. This strong consumer intent underscores the robust demand for photomedicine solutions, provided that economic and regulatory challenges are effectively navigated.

Market Driver

The escalating incidence of ophthalmic and dermatological disorders acts as a major catalyst for the adoption of photomedicine technologies. As the prevalence of chronic conditions and skin malignancies rises, there is a critical requirement for precise diagnostic and therapeutic tools, such as advanced laser systems and photodynamic therapy. These technologies enable targeted lesion treatment with minimal harm to surrounding tissues, rendering them essential in modern oncology and dermatology. Underscoring this urgency, the American Cancer Society's 'Cancer Facts & Figures 2025' report from January 2025 estimates that 212,200 cases of melanoma will be diagnosed in the U.S. in 2025, highlighting the vital role of light-based interventions in managing complex skin diseases.

Concurrently, the surging demand for minimally invasive aesthetic procedures is transforming the market landscape. Patients are increasingly prioritizing cosmetic enhancements that deliver effective results without the downtime and risks linked to traditional surgery, driving the uptake of non-surgical tightening devices and laser skin resurfacing. This trend is reinforced by technological innovations that improve safety and efficacy across various skin types. According to the International Society of Aesthetic Plastic Surgery's June 2025 'Global Survey on Aesthetic/Cosmetic Procedures', practitioners performed 20.5 million non-surgical procedures worldwide in 2024, signaling a massive shift toward these less invasive modalities. This commercial viability is reflected in industry performance; for instance, Sisram Medical announced in March 2025 that it achieved a total revenue of US$349.1 million for the fiscal year 2024, largely supported by robust sales of its energy-based device portfolio.

Market Challenge

The substantial capital expenditure required to acquire advanced photomedicine systems presents a formidable barrier to the widespread adoption of laser technology, directly hindering market expansion. Medical-grade devices impose a massive financial burden on healthcare providers, particularly independent dermatologists and smaller aesthetic clinics that lack the financial leverage of large hospital networks. This high entry cost forces practitioners to maintain elevated procedure prices to ensure a viable return on investment, which effectively prevents the commoditization of these services. Consequently, the technology remains financially inaccessible to a broader demographic, limiting the total addressable market to affluent patient segments and stalling mass-market penetration.

This economic friction creates a direct bottleneck in converting consumer interest into actual revenue growth. The downstream effect of these equipment costs is evident in patient behavior regarding treatment affordability. According to the American Society for Dermatologic Surgery in 2025, 24% of consumers cited cost as the primary reason for delaying or avoiding desired cosmetic procedures. This statistic demonstrates that the financial burden of high-cost technology is passed on to the patient, creating a price ceiling that significantly dampens procedure volume and hampers the overall trajectory of the Global Photomedicine Technology Market.

Market Trends

The integration of Artificial Intelligence for precision dosimetry and treatment personalization is fundamentally reshaping the Global Photomedicine Technology Market by replacing manual parameter selection with automated, data-driven protocols. This technological advancement allows sophisticated laser and light systems to analyze patient skin characteristics in real-time, dynamically adjusting energy fluence and pulse duration to maximize therapeutic efficacy while minimizing thermal damage. Manufacturers are increasingly prioritizing these intelligent control features to differentiate their flagship platforms and meet the demand for consistent, operator-independent clinical outcomes. This strategic focus on smart automation is yielding tangible financial results; according to Sciton's March 2025 announcement regarding its '28 Years of Growth', the company's AI-enhanced BBL HEROic system drove a 7% year-over-year revenue increase for its light-based treatment portfolio, validating the market's shift towards intelligent, self-regulating dosimetric technologies.

Simultaneously, the proliferation of smart wearable and handheld home-use phototherapy devices is creating a massive secondary market that complements professional clinical services. Driven by the miniaturization of therapeutic components, consumers are rapidly adopting FDA-cleared LED masks and handheld laser devices that offer accessible management for conditions such as acne, alopecia, and photoaging. This trend effectively circumvents the high acquisition costs associated with professional medical systems, allowing manufacturers to tap into a broader demographic seeking convenient, ongoing skin maintenance. The commercial scale of this consumer segment is becoming increasingly significant; according to City AM in February 2025, the home-use device retailer CurrentBody reported that its annual revenue surpassed £100 million for the first time in 2024, underscoring the explosive demand for personal photomedicine solutions.

Key Market Players

• Sisram Medical Ltd
• Beurer GmbH
• Biolitec AG
• Koninklijke Philips NV
• Lumenis Inc.
• Photomedex Inc.
• LUMIBIRD Inc.
• Candela Corporation
• Thor Photomedicine Ltd
• Johnson & Johnson

Report Scope

In this report, the Global Photomedicine Technology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Photomedicine Technology Market, By Application

• Aesthetics and Dermatology (Hair Removal, Tattoo Removal, Skin Resurfacing, Other)
• Dental Procedures
• Oncology
• Ophthalmology
• Pain Management
• Wound Healing
• and Other

Photomedicine Technology Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Photomedicine Technology Market.

Available Customizations:

Global Photomedicine Technology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Photomedicine Technology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Aesthetics and Dermatology (Hair Removal, Tattoo Removal, Skin Resurfacing, Other), Dental Procedures, Oncology, Ophthalmology, Pain Management, Wound Healing, and Other)
  • 5.2.2. By Region
  • 5.2.3. By Company (2025)
• 5.3. Market Map

6. North America Photomedicine Technology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Photomedicine Technology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
  • 6.3.2. Canada Photomedicine Technology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
  • 6.3.3. Mexico Photomedicine Technology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application

7. Europe Photomedicine Technology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Photomedicine Technology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
  • 7.3.2. France Photomedicine Technology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
  • 7.3.3. United Kingdom Photomedicine Technology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
  • 7.3.4. Italy Photomedicine Technology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
  • 7.3.5. Spain Photomedicine Technology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application

8. Asia Pacific Photomedicine Technology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Photomedicine Technology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
  • 8.3.2. India Photomedicine Technology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
  • 8.3.3. Japan Photomedicine Technology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
  • 8.3.4. South Korea Photomedicine Technology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
  • 8.3.5. Australia Photomedicine Technology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application

9. Middle East & Africa Photomedicine Technology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Photomedicine Technology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
  • 9.3.2. UAE Photomedicine Technology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
  • 9.3.3. South Africa Photomedicine Technology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application

10. South America Photomedicine Technology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Photomedicine Technology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
  • 10.3.2. Colombia Photomedicine Technology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
  • 10.3.3. Argentina Photomedicine Technology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Photomedicine Technology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Sisram Medical Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Beurer GmbH
• 15.3. Biolitec AG
• 15.4. Koninklijke Philips NV
• 15.5. Lumenis Inc.
• 15.6. Photomedex Inc.
• 15.7. LUMIBIRD Inc.
• 15.8. Candela Corporation
• 15.9. Thor Photomedicine Ltd
• 15.10. Johnson & Johnson

16. Strategic Recommendations

17. About Us & Disclaimer